126 related articles for article (PubMed ID: 15645567)
1. Bitter orange weight loss products may not be safe.
Health News; 2004 Dec; 10(12):9. PubMed ID: 15645567
[No Abstract] [Full Text] [Related]
2. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.
Stohs SJ; Preuss HG; Shara M
Phytother Res; 2011 Oct; 25(10):1421-8. PubMed ID: 21480414
[TBL] [Abstract][Full Text] [Related]
3. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.
Nykamp DL; Fackih MN; Compton AL
Ann Pharmacother; 2004 May; 38(5):812-6. PubMed ID: 15026566
[TBL] [Abstract][Full Text] [Related]
4. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions.
Jordan S; Murty M; Pilon K
CMAJ; 2004 Oct; 171(8):993-4. PubMed ID: 15497209
[No Abstract] [Full Text] [Related]
5. Ephedra-free is not danger-free.
Marcus DM; Grollman AP
Science; 2003 Sep; 301(5640):1669-71; author reply 1669-71. PubMed ID: 14500960
[No Abstract] [Full Text] [Related]
6. Consumption of dietary supplements containing Citrus aurantium (bitter orange)--2004 California Behavioral Risk Factor Surveillance Survey (BRFSS).
Klontz KC; Timbo BB; Street D
Ann Pharmacother; 2006 Oct; 40(10):1747-51. PubMed ID: 16968826
[TBL] [Abstract][Full Text] [Related]
7. Reporting associations between dietary supplements and adverse events.
McGuffin M
Mayo Clin Proc; 2006 Dec; 81(12):1636; author reply 1636-7. PubMed ID: 17165644
[No Abstract] [Full Text] [Related]
8. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain?
Allison DB; Cutter G; Poehlman ET; Moore DR; Barnes S
Int J Obes (Lond); 2005 Apr; 29(4):443-6. PubMed ID: 15700046
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric determination of the predominant adrenergic protoalkaloids in bitter orange (Citrus aurantium).
Nelson BC; Putzbach K; Sharpless KE; Sander LC
J Agric Food Chem; 2007 Nov; 55(24):9769-75. PubMed ID: 17966980
[TBL] [Abstract][Full Text] [Related]
10. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.
Sultan S; Spector J; Mitchell RM
Mayo Clin Proc; 2006 Dec; 81(12):1630-1. PubMed ID: 17165643
[TBL] [Abstract][Full Text] [Related]
11. [Risk assessment of synephrine in dietary supplements].
Bakhyia N; Dusemund B; Richter K; Lindtner O; Hirsch-Ernst KI; Schäfer B; Lampen A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):323-331. PubMed ID: 28058460
[TBL] [Abstract][Full Text] [Related]
12. Review of Published Bitter Orange Extract and
Stohs SJ; Ray SD
J Diet Suppl; 2020; 17(3):355-363. PubMed ID: 30835576
[No Abstract] [Full Text] [Related]
13. Citrus aurantium--beware of the bitter orange.
Louw VJ; Louw H
S Afr Med J; 2008 Jul; 98(7):496. PubMed ID: 18785379
[No Abstract] [Full Text] [Related]
14. Response of CEDIA amphetamines assay after a single dose of bitter orange.
Nguyen DT; Bui LT; Ambrose PJ
Ther Drug Monit; 2006 Apr; 28(2):252-4. PubMed ID: 16628139
[TBL] [Abstract][Full Text] [Related]
15. [Synephrine in dietary supplements and specialized foodstuffs: biological activity, safety and methods of analysis].
Perova IB; Eller KI; Musatov AV; Tymolskaya EV
Vopr Pitan; 2021; 90(6):101-113. PubMed ID: 35032130
[TBL] [Abstract][Full Text] [Related]
16. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement.
Burke J; Seda G; Allen D; Knee TS
Mil Med; 2007 Jun; 172(6):656-8. PubMed ID: 17615852
[TBL] [Abstract][Full Text] [Related]
17. "Ephedra-free" diet pill-induced psychosis.
Retamero C; Rivera T; Murphy K
Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
[No Abstract] [Full Text] [Related]
18. A rapid liquid chromatography electrospray ionization mass spectrometry(n) method for evaluation of synephrine in Citrus aurantium L. samples.
Mattoli L; Cangi F; Maidecchi A; Ghiara C; Tubaro M; Traldi P
J Agric Food Chem; 2005 Dec; 53(26):9860-6. PubMed ID: 16366666
[TBL] [Abstract][Full Text] [Related]
19. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update.
Haaz S; Fontaine KR; Cutter G; Limdi N; Perumean-Chaney S; Allison DB
Obes Rev; 2006 Feb; 7(1):79-88. PubMed ID: 16436104
[TBL] [Abstract][Full Text] [Related]
20. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine.
Stohs SJ
Phytother Res; 2017 Oct; 31(10):1463-1474. PubMed ID: 28752649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
